E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/24/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: pSivida closes $4.2 million private placement of American depositary receipts

By Sheri Kasprzak

New York, Aug. 24 - pSivida Ltd. said it has wrapped a private placement of American depositary receipts for $4,225,000.

The company sold 650,000 ADRs at $6.50 each to mostly U.S.-based investors.

Each ADR represent 10 common shares, and the ADRs have an attached 1-for-10 warrant, exercisable at $12.50 each for three years.

Based in Perth, Australia, pSivida is a nanotechnology company focused on the biomedical sector. The proceeds will be used for the company's expansion into the United States.

Issuer:pSivida Ltd.
Issue:American depositary receipts representing 10 common shares each
Amount:$4,225,000
ADRs:650,000
Price:$6.50
Warrants:One warrant for 10 shares per ADR
Warrant expiration:Three years
Warrant strike price:$12.50
Settlement date:Aug. 24
Stock price:$6.60 at close Aug. 23

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.